Transcode Therapeutics, Inc.
Total Trades
7
Buys
7
Sells
0
Largest Trade
$50K–$100K
Insiders
2
Institutional Funds
2
Inst. Value
$15K–$50K
Activist Filings
21
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Fitzgerald Thomas A | CFO | BUY | $15K–$50K | 49K | $0.51 | Oct 2, 2023 |
| Dudley Robert Michael | CEO | BUY | $15K–$50K | 98K | $0.51 | Oct 2, 2023 |
| Dudley Robert Michael | CEO | BUY | $15K–$50K | 19K | $2.62 | Jun 22, 2023 |
| Dudley Robert Michael | CEO | BUY | $50K–$100K | 19K | $2.76 | Jun 13, 2023 |
| Dudley Robert Michael | CEO | BUY | $15K–$50K | 20K | $1.15 | Sep 16, 2022 |
| Fitzgerald Thomas A | CFO | BUY | $15K–$50K | 12K | $1.27 | Jun 17, 2022 |
| Dudley Robert Michael | CEO | BUY | $50K–$100K | 30K | $1.85 | Jun 1, 2022 |
Institutional Ownership
13F filings as of Dec 31, 2025 · 2 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| UBS Group AG | 3K | $15K–$50K | SH |
| SBI Securities Co., Ltd. | 10 | <$1K | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13G/A · Jan 7, 2026
4.9%
42K shares
SC 13G/A · Nov 10, 2025
0.0%
82 shares
CK Life Sciences Int'l., (Holdings) Inc.
SC 13D/A · Oct 28, 2025
9.1%
83K shares
CK Life Sciences Int'l., (Holdings) Inc.
SC 13D · Oct 16, 2025
9.1%
83K shares
SC 13G/A · Aug 15, 2025
0.1%
27K shares
SC 13G · Aug 14, 2025
5.9%
49K shares
SC 13D · Mar 20, 2025
5.0%
35K shares
SC 13G · Feb 14, 2025
9.9%
113K shares
SC 13G · Jan 4, 2025
9.9%
70K shares
SC 13G/A · Nov 6, 2024
0.0%
0 shares
SC 13G · Jul 26, 2024
9.9%
1.7M shares
SC 13D · Jun 21, 2024
5.5%
422K shares
SC 13G/A · Feb 15, 2024
0.4%
112K shares
SC 13G/A · Feb 10, 2023
12.7%
1.7M shares
SC 13D · Jan 13, 2023
8.5%
9.6M shares
SC 13D · Jan 13, 2023
9.7%
11.0M shares
SC 13D · Dec 19, 2022
12.7%
1.8M shares
SC 13G · Dec 19, 2022
12.5%
1.6M shares
SC 13G · Dec 19, 2022
10.6%
1.4M shares
SC 13G/A · Oct 27, 2022
0.0%
0 shares
SC 13G/A · Feb 11, 2022
9.9%
1.3M shares